CARA Stock Overview
Provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Carasent ASA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NOK 19.50 |
52 Week High | NOK 20.30 |
52 Week Low | NOK 9.81 |
Beta | 0.50 |
11 Month Change | 5.41% |
3 Month Change | 4.28% |
1 Year Change | 69.57% |
33 Year Change | -53.13% |
5 Year Change | 109.68% |
Change since IPO | -62.50% |
Recent News & Updates
Recent updates
Carasent ASA's (OB:CARA) 32% Jump Shows Its Popularity With Investors
Apr 25Calculating The Fair Value Of Carasent ASA (OB:CARA)
Dec 22Is It Too Late To Consider Buying Carasent ASA (OB:CARA)?
Nov 16Carasent's (OB:CARA) Returns On Capital Are Heading Higher
Sep 07Carasent ASA's (OB:CARA) Intrinsic Value Is Potentially 73% Above Its Share Price
May 11Is Carasent ASA (OB:CARA) Potentially Undervalued?
Mar 18Is Now The Time To Look At Buying Carasent ASA (OB:CARA)?
Nov 22Carasent's (OB:CARA) Solid Profits Have Weak Fundamentals
May 06Returns Are Gaining Momentum At Carasent (OB:CARA)
Apr 29Carasent ASA Beat Analyst Profit Forecasts, And Analysts Have New Estimates
Feb 13There Are Reasons To Feel Uneasy About Carasent's (OB:CARA) Returns On Capital
Nov 24Calculating The Intrinsic Value Of Carasent ASA (OB:CARA)
May 23We Like These Underlying Trends At Carasent (OB:CARA)
Feb 28What Type Of Shareholders Own The Most Number of Carasent ASA (OB:CARA) Shares?
Jan 24Shareholder Returns
CARA | NO Healthcare Services | NO Market | |
---|---|---|---|
7D | 0.8% | 1.8% | 0.6% |
1Y | 69.6% | 31.4% | 2.4% |
Return vs Industry: CARA exceeded the Norwegian Healthcare Services industry which returned 31.4% over the past year.
Return vs Market: CARA exceeded the Norwegian Market which returned 2.4% over the past year.
Price Volatility
CARA volatility | |
---|---|
CARA Average Weekly Movement | 4.5% |
Healthcare Services Industry Average Movement | 5.4% |
Market Average Movement | 5.1% |
10% most volatile stocks in NO Market | 10.8% |
10% least volatile stocks in NO Market | 2.7% |
Stable Share Price: CARA has not had significant price volatility in the past 3 months compared to the Norwegian market.
Volatility Over Time: CARA's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1997 | 169 | Daniel Ohman | carasent.com |
Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institute AB (HPI), an occupational care platform; Ad Curis, a record system with digital services tailored for the specialist healthcare service with clients in rehabilitation, interdisciplinary specialized drug treatment, and mental health care, as well as businesses in care and prevention; and Ad Opus, a journal system for follow-up of participants in measures. It also provides platform services, such as Vårdrummet, Confrere, Ad Voca, electronic letters, SMS services, portal to medical services, and consulting and other services.
Carasent ASA Fundamentals Summary
CARA fundamental statistics | |
---|---|
Market cap | NOK 1.38b |
Earnings (TTM) | -NOK 7.94m |
Revenue (TTM) | NOK 264.80m |
5.3x
P/S Ratio-177.7x
P/E RatioIs CARA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CARA income statement (TTM) | |
---|---|
Revenue | NOK 264.80m |
Cost of Revenue | NOK 42.52m |
Gross Profit | NOK 222.27m |
Other Expenses | NOK 230.21m |
Earnings | -NOK 7.94m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
Earnings per share (EPS) | -0.11 |
Gross Margin | 83.94% |
Net Profit Margin | -3.00% |
Debt/Equity Ratio | 0% |
How did CARA perform over the long term?
See historical performance and comparison